Clinical efficacies of C. E. R. A. (Continuous Erythropoietin Receptor Activator) administered intravenously to epoetin (EPO) naïve renal anemia patients on hemodialysis - Phase III study

Yuzo Watanabe, Noritomo Itami, Nobuo Hashimoto, Akira Kurosawa, Kazue Ueki, Yasufumi Irie, Ryoichi Ando, Hisao Muto, Yutaka Kanno, Chikao Yamazaki, Akira Ito, Hiroshi Ogawa, Tomohiko Naruse, Daijyo Inaguma, Hirotake Kasuga, Katsushi Koyama, Takashi Sato, Toshihiko Ono, Yasushi Saika, Munesuke MatsumotoMasafumi Taki, Masaki Fukushima, Jun Minakuchi, Kenji Yuasa, Susumu Miyake, Kazuhito Takeda, Akiyo Shiroozu, Seiya Okuda, Masahiko Nakamoto, Kei Hori, Kenichi Fukunari, Masami Bessho, Masashi Suzuki

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical efficacies of C. E. R. A. (Continuous Erythropoietin Receptor Activator) administered intravenously to epoetin (EPO) naïve renal anemia patients on hemodialysis - Phase III study'. Together they form a unique fingerprint.

Medicine & Life Sciences